Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ipragliflozin vs sitagliptin added to metformin in type 2 diabetes (Japanese adults without prior ASCVD)
jRCTs031180205Completed
- Sponsor
- Astellas Pharma
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in type 2 diabetes mellitus (T2DM) comparing Metformin + ipragliflozin with Metformin + sitagliptin (2 arms). Started Nov 2015; status: completed.
02
Drugs
ipragliflozinsitagliptinmetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCTs031180205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180205.